Global Drug Eluting Balloons Catheters Market Comprehensive Study: Forecasted Market Size And Growth Rate | Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktienge

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2102

The Business Research Company offers in-depth market insights through Drug Eluting Balloons Catheters Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population..

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design.. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

Market Segmentation:
The main types of products included in drug-eluting balloon catheters are coronary artery disease drug-eluting balloon catheters and peripheral vascular disease drug-eluting balloon catheters. Coronary artery disease drug-eluting balloon catheters refer to balloon catheters designed to deliver antiproliferative drugs directly to the vessel wall via a lipophilic matrix, removing the requirement for a lasting structure such as a metal prosthesis or a persistent polymer. Various types of drugs are used, including paclitaxel, sirolimus, and others. These are made of several raw materials, including nylon, polyurethane, and others, and are used by numerous end-users, such as hospitals and clinics, ambulatory surgical centers, and catheterization laboratories.

Major Driver - Expanding Prevalence Of Cardiovascular And Peripheral Diseases Fuels Drug-Eluting Balloon Catheter Market Growth
The growing prevalence of peripheral and cardiovascular diseases is expected to propel the growth of the drug-eluting balloon catheter market going forward. Cardiovascular diseases (CVDs) refer to a group of conditions that impact the heart and the circulatory system, whereas peripheral artery disease (PAD) specifically refers to a condition where narrowed arteries reduce blood flow primarily to the arms or legs. Drug-eluting balloon catheters are a type of treatment for coronary artery disease (CAD) that uses a semi-compliant angioplasty balloon coated with an anti-proliferative substance that, when it enters the vessel, can have an anti-restenotic effect. For instance, in April 2023, according to the British Heart Foundation, a UK-based cardiovascular research charity, the number of deaths from coronary heart disease in the UK in 2021 was 65,579, up from 64,170 in 2020. Furthermore, in April 2023, according to HMP Global, a US-based multi-accredited patient-centered education company, it is projected that the prevalence of peripheral arterial disease in the US will reach 23.8 million in 2030, up from 21.0 million in 2020. Therefore, the growing prevalence of peripheral and cardiovascular diseases is driving the drug-eluting balloon catheter market.

Competitive Landscape:
Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Top Trend - Introducing Newest-Generation Products For Advancing Coronary Artery Disease Treatment
Major companies operating in the drug-eluting balloon catheter market are increasing their focus on developing the newest-generation products with advanced technologies to gain a competitive edge in the market. For instance, in July 2021, Medtronic PLC, an Ireland-based medical technology company, launched Prevail DCB in Europe, its latest-generation drug-coated balloon catheter for the treatment of coronary artery disease. This device is specifically designed for use in PCI (percutaneous coronary intervention) procedures, assisting in the treatment of constricted or obstructed coronary arteries associated with coronary artery disease (CAD). The Prevail DCB employs paclitaxel, a drug that's quickly absorbed, to effectively treat new lesions, issues in small vessels, and in-stent restenosis (ISR). Furthermore, by integrating PowerTrac, a cutting-edge technology previously found in the delivery system for the Medtronic Resolute Onyx DES, it provides superior deliverability and pushing power.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Drug Eluting Balloons Catheters Market Characteristics
3. Drug Eluting Balloons Catheters Market Trends And Strategies
4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario
5. Drug Eluting Balloons Catheters Market Size And Growth
…..
27. Drug Eluting Balloons Catheters Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.